Sep. 29, 2009 (World Stock Wire) --
Las Vegas, NV - (WORLD STOCK WIRE) - September 29, 2009 -- CRWESelect.com tracks stocks daily and is pleased to offer its investors a sizzling stock watch highlight alert. Investors can receive FREE Stock Highlight Alerts by visiting CRWESelect.com at the following link: http://www.crweselect.com
Power 3 Medical Products Inc, (PWRM)
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.
PWRM's NuroPro PD test was developed to help clinicians distinguish patients with Parkinson's disease from "normal" individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson's disease.
PWRM and Transgenomic, Inc. (OTCBB:TBIO) announced recently the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson's disease patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.
PWRM's Chief Scientific Officer is Chair and Keynote Speaker of Session at the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing, China in November 2009
More about PWRM at www.power3medical.com
Cavitation Technologies Inc (CVAT)
CVAT is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the, vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, chemical industries.
Biocombustibles y Energias Alternativas (ALS) has entered into a long-term agreement with CVAT to develop projects in Argentina and throughout Latin America. ALS (www.alsbio.com), partnering with DOW Chemical (www.dow.com), has identified several projects where CVAT technology can greatly improve process yields and profitability using CTI and DOW proprietary technology.
These first projects in Argentina represent 480,000 metric tons of fuel per year and more than a $2,500,000 in sales revenue for CVAT
CVAT More about CVAT at www.cavitationtechnologies.com
SOHM Inc., (SHMN)
SHMN is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India.
